{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:50:49Z","timestamp":1787003449836,"version":"build-2736575974"},"reference-count":157,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T00:00:00Z","timestamp":1661299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T00:00:00Z","timestamp":1661299200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1038\/s41581-022-00618-4","type":"journal-article","created":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T11:03:55Z","timestamp":1661339035000},"page":"724-737","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":76,"title":["Impact of the COVID-19 pandemic on the kidney community: lessons learned and future directions"],"prefix":"10.1038","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8353-5542","authenticated-orcid":false,"given":"Duvuru","family":"Geetha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2945-2946","authenticated-orcid":false,"given":"Andreas","family":"Kronbichler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Rutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Bajpai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2490-025X","authenticated-orcid":false,"given":"Steven","family":"Menez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemarie","family":"Weissenbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuchi","family":"Anand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Carlson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Sozio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Fowler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ray","family":"Bignall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Ducharlet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliot K.","family":"Tannor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eranga","family":"Wijewickrama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad I. A.","family":"Hafidz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Tesar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Hoover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deidra","family":"Crews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Varnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Danziger-Isakov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8015-9470","authenticated-orcid":false,"given":"Vivekanand","family":"Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumit","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9051-7385","authenticated-orcid":false,"given":"Chirag","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Luyckx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,24]]},"reference":[{"key":"618_CR1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1681\/ASN.2020050615","volume":"32","author":"L Chan","year":"2021","unstructured":"Chan, L. et al. AKI in hospitalized patients with COVID-19. J. Am. Soc. Nephrol. 32, 151\u2013160 (2021).","journal-title":"J. Am. Soc. Nephrol."},{"key":"618_CR2","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1159\/000519530","volume":"146","author":"M Brogan","year":"2022","unstructured":"Brogan, M. & Ross, M. J. The impact of chronic kidney disease on outcomes of patients with COVID-19 admitted to the intensive care unit. Nephron 146, 67\u201371 (2022).","journal-title":"Nephron"},{"key":"618_CR3","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1111\/ajt.15941","volume":"20","author":"MR Pereira","year":"2020","unstructured":"Pereira, M. R. et al. COVID-19 in solid organ transplant recipients: initial report from the US epicenter. Am. J. Transpl. 20, 1800\u20131808 (2020).","journal-title":"Am. J. Transpl."},{"key":"618_CR4","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1016\/j.ekir.2021.05.026","volume":"6","author":"M Singhala","year":"2021","unstructured":"Singhala, M. et al. Emergency production and collection of dialysate for CVVHD during the COVID-19 pandemic. Kidney Int. Rep. 6, 2200\u20132202 (2021).","journal-title":"Kidney Int. Rep."},{"key":"618_CR5","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1093\/ndt\/gfab007","volume":"36","author":"C Combe","year":"2021","unstructured":"Combe, C. et al. At least 156 reasons to prioritize COVID-19 vaccination in patients receiving in-centre haemodialysis. Nephrol. Dial. Transpl. 36, 571\u2013574 (2021).","journal-title":"Nephrol. Dial. Transpl."},{"key":"618_CR6","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.ccc.2022.01.002","volume":"38","author":"J Hilton","year":"2022","unstructured":"Hilton, J., Boyer, N., Nadim, M. K., Forni, L. G. & Kellum, J. A. COVID-19 and acute kidney injury. Crit. Care Clin. 38, 473\u2013489 (2022).","journal-title":"Crit. Care Clin."},{"key":"618_CR7","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.kint.2020.05.006","volume":"98","author":"JS Hirsch","year":"2020","unstructured":"Hirsch, J. S. et al. Acute kidney injury in patients hospitalized with COVID-19. Kidney Int. 98, 209\u2013218 (2020).","journal-title":"Kidney Int."},{"key":"618_CR8","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/j.ekir.2021.01.036","volume":"6","author":"DM Charytan","year":"2021","unstructured":"Charytan, D. M. et al. Decreasing incidence of acute kidney injury in patients with COVID-19 critical illness in New York City. Kidney Int. Rep. 6, 916\u2013927 (2021).","journal-title":"Kidney Int. Rep."},{"key":"618_CR9","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.xkme.2021.06.008","volume":"3","author":"S Dellepiane","year":"2021","unstructured":"Dellepiane, S. et al. Acute kidney injury in patients hospitalized with COVID-19 in New York City: temporal trends from March 2020 to April 2021. Kidney Med. 3, 877\u2013879 (2021).","journal-title":"Kidney Med."},{"key":"618_CR10","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1016\/j.ekir.2021.06.019","volume":"6","author":"EK Tannor","year":"2021","unstructured":"Tannor, E. K. Challenges in kidney care in a lower middle income country during the COVID-19 pandemic \u2014 the Ghanaian perspective. Kidney Int. Rep. 6, 2014\u20132016 (2021).","journal-title":"Kidney Int. Rep."},{"key":"618_CR11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.18772\/26180197.2020.v2n3a13","volume":"2","author":"NE Diane","year":"2020","unstructured":"Diane, N. E. et al. Acute kidney injury during the COVID-19 pandemic\u2013experience from two tertiary centres in South Africa. 2020. Wits J. Clin. Med. 2, 189\u2013198 (2020).","journal-title":"Wits J. Clin. Med."},{"key":"618_CR12","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/j.kint.2021.07.015","volume":"100","author":"RM May","year":"2021","unstructured":"May, R. M. et al. A multi-center retrospective cohort study defines the spectrum of kidney pathology in Coronavirus 2019 Disease (COVID-19). Kidney Int. 100, 1303\u20131315 (2021).","journal-title":"Kidney Int."},{"key":"618_CR13","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1681\/ASN.2020050558","volume":"31","author":"H Wu","year":"2020","unstructured":"Wu, H. et al. AKI and collapsing glomerulopathy associated with COVID-19 and APOL 1 high-risk genotype. J. Am. Soc. Nephrol. 31, 1688 (2020).","journal-title":"J. Am. Soc. Nephrol."},{"key":"618_CR14","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2021.8538","author":"AM Hung","year":"2022","unstructured":"Hung, A. M. et al. APOL1 risk variants, acute kidney injury, and death in participants with African ancestry hospitalized with COVID-19 from the million veteran program. JAMA Intern. Med. https:\/\/doi.org\/10.1001\/jamainternmed.2021.8538 (2022).","journal-title":"JAMA Intern. Med."},{"key":"618_CR15","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1016\/j.ekir.2021.07.008","volume":"6","author":"IA Strohbehn","year":"2021","unstructured":"Strohbehn, I. A. et al. Acute kidney injury incidence, recovery, and long-term kidney outcomes among hospitalized patients with COVID-19 and influenza. Kidney Int. Rep. 6, 2565\u20132574 (2021).","journal-title":"Kidney Int. Rep."},{"key":"618_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-021-00914-5","volume":"11","author":"N Lumlertgul","year":"2021","unstructured":"Lumlertgul, N. et al. Acute kidney injury prevalence, progression and long-term outcomes in critically ill patients with COVID-19: a cohort study. Ann. Intensive Care 11, 123 (2021).","journal-title":"Ann. Intensive Care"},{"key":"618_CR17","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1681\/ASN.2020060897","volume":"32","author":"S Gupta","year":"2021","unstructured":"Gupta, S. et al. AKI treated with renal replacement therapy in critically ill patients with COVID-19. J. Am. Soc. Nephrol. 32, 161\u2013176 (2021).","journal-title":"J. Am. Soc. Nephrol."},{"key":"618_CR18","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/s41581-021-00487-3","volume":"17","author":"S Yende","year":"2021","unstructured":"Yende, S. & Parikh, C. R. Long COVID and kidney disease. Nat. Rev. Nephrol. 17, 792\u2013793 (2021).","journal-title":"Nat. Rev. Nephrol."},{"key":"618_CR19","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1681\/ASN.2021060734","volume":"32","author":"B Bowe","year":"2021","unstructured":"Bowe, B., Xie, Y., Xu, E. & Al-Aly, Z. Kidney outcomes in long COVID. J. Am. Soc. Nephrol. 32, 2851\u20132862 (2021).","journal-title":"J. Am. Soc. Nephrol."},{"key":"618_CR20","doi-asserted-by":"publisher","first-page":"242","DOI":"10.34067\/KID.0005342021","volume":"3","author":"S Sun","year":"2022","unstructured":"Sun, S. et al. Short- and long-term recovery after moderate\/severe AKI in patients with and without COVID-19. Kidney360 3, 242\u2013257 (2022).","journal-title":"Kidney360"},{"key":"618_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2022.05.015","author":"A Dashtban","year":"2022","unstructured":"Dashtban, A. et al. A retrospective cohort study measured predicting and validating the impact of the COVID-19 pandemic in individuals with chronic kidney disease. Kidney Int. https:\/\/doi.org\/10.1016\/j.kint.2022.05.015 (2022).","journal-title":"Kidney Int."},{"key":"618_CR22","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s40620-020-00790-5","volume":"33","author":"A Uribarri","year":"2020","unstructured":"Uribarri, A. et al. Impact of renal function on admission in COVID-19 patients: an analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID 19) registry. J. Nephrol. 33, 737\u2013745 (2020).","journal-title":"J. Nephrol."},{"key":"618_CR23","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1093\/ndt\/gfaa189","volume":"35","author":"J Portoles","year":"2020","unstructured":"Portoles, J. et al. Chronic kidney disease and acute kidney injury in the COVID-19 Spanish outbreak. Nephrol. Dial. Transpl. 35, 1353\u20131361 (2020).","journal-title":"Nephrol. Dial. Transpl."},{"key":"618_CR24","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/joim.13239","volume":"290","author":"N Carlson","year":"2021","unstructured":"Carlson, N. et al. Increased vulnerability to COVID-19 in chronic kidney disease. J. Intern. Med. 290, 166\u2013178 (2021).","journal-title":"J. Intern. Med."},{"key":"618_CR25","doi-asserted-by":"publisher","first-page":"649336","DOI":"10.3389\/fphys.2021.649336","volume":"12","author":"S Hakroush","year":"2021","unstructured":"Hakroush, S., Tampe, D., Korsten, P. & Tampe, B. Impact of the COVID-19 pandemic on kidney diseases requiring renal biopsy: a single center observational study. Front. Physiol. 12, 649336 (2021).","journal-title":"Front. Physiol."},{"key":"618_CR26","doi-asserted-by":"publisher","DOI":"10.1177\/11297298211045578","author":"C Seet","year":"2021","unstructured":"Seet, C. et al. The management of dialysis access thrombosis during the COVID-19 pandemic. J. Vasc. Access https:\/\/doi.org\/10.1177\/11297298211045578 (2021).","journal-title":"J. Vasc. Access"},{"key":"618_CR27","doi-asserted-by":"publisher","first-page":"2948","DOI":"10.1681\/ASN.2021040579","volume":"32","author":"JB Wetmore","year":"2021","unstructured":"Wetmore, J. B. et al. Changes in treatment of patients with incident ESKD during the novel coronavirus disease 2019 pandemic. J. Am. Soc. Nephrol. 32, 2948\u20132957 (2021).","journal-title":"J. Am. Soc. Nephrol."},{"key":"618_CR28","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1053\/j.ackd.2020.06.003","volume":"27","author":"T Truong","year":"2020","unstructured":"Truong, T., Dittmar, M., Ghaffari, A. & Lin, E. Policy and pandemic: the changing practice of nephrology during the coronavirus disease-2019 outbreak. Adv. Chronic Kidney Dis. 27, 390\u2013396 (2020).","journal-title":"Adv. Chronic Kidney Dis."},{"key":"618_CR29","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1080\/0886022X.2020.1798783","volume":"42","author":"G Chen","year":"2020","unstructured":"Chen, G. et al. When the COVID-19 pandemic changed the follow-up landscape of chronic kidney disease: a survey of real-world nephrology practice. Ren. Fail. 42, 733\u2013739 (2020).","journal-title":"Ren. Fail."},{"key":"618_CR30","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.kint.2020.04.019","volume":"98","author":"R Ramachandran","year":"2020","unstructured":"Ramachandran, R. & Jha, V. Adding insult to injury: kidney replacement therapy during COVID-19 in India. Kidney Int. 98, 238\u2013239 (2020).","journal-title":"Kidney Int."},{"key":"618_CR31","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMoa2021436","volume":"384","author":"RC Group","year":"2021","unstructured":"Group, R. C. et al. Dexamethasone in hospitalized patients with COVID-19. N. Engl. J. Med. 384, 693\u2013704 (2021).","journal-title":"N. Engl. J. Med."},{"key":"618_CR32","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1681\/ASN.2020050589","volume":"31","author":"ML Adamsick","year":"2020","unstructured":"Adamsick, M. L. et al. Remdesivir in patients with acute or chronic kidney disease and COVID-19. J. Am. Soc. Nephrol. 31, 1384\u20131386 (2020).","journal-title":"J. Am. Soc. Nephrol."},{"key":"618_CR33","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1001\/jamainternmed.2020.6615","volume":"181","author":"C Salvarani","year":"2021","unstructured":"Salvarani, C. et al. Effect of tocilizumab vs standard care on clinical worsening in patients hospitalized with COVID-19 pneumonia: a randomized clinical trial. JAMA Intern. Med. 181, 24\u201331 (2021).","journal-title":"JAMA Intern. Med."},{"key":"618_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9080885","author":"YC Hou","year":"2021","unstructured":"Hou, Y. C., Lu, K. C. & Kuo, K. L. The efficacy of COVID-19 vaccines in chronic kidney disease and kidney transplantation patients: a narrative review. Vaccines https:\/\/doi.org\/10.3390\/vaccines9080885 (2021).","journal-title":"Vaccines"},{"key":"618_CR35","doi-asserted-by":"publisher","first-page":"872","DOI":"10.2215\/CJN.01770222","volume":"17","author":"B Quiroga","year":"2022","unstructured":"Quiroga, B. et al. Humoral response to third dose of SARS-CoV-2 vaccines in the CKD spectrum. Clin. J. Am. Soc. Nephrol. 17, 872\u2013876 (2022).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"618_CR36","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1016\/j.ekir.2021.08.009","volume":"6","author":"A Salas","year":"2021","unstructured":"Salas, A. et al. ANCA vasculitis induction management during the COVID-19 pandemic. Kidney Int. Rep. 6, 2903\u20132907 (2021).","journal-title":"Kidney Int. Rep."},{"key":"618_CR37","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.kint.2020.10.032","volume":"99","author":"M Waldman","year":"2021","unstructured":"Waldman, M. et al. Results from the IRoc-GN international registry of patients with COVID-19 and glomerular disease suggest close monitoring. Kidney Int. 99, 227\u2013237 (2021).","journal-title":"Kidney Int."},{"key":"618_CR38","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1136\/annrheumdis-2020-219498","volume":"80","author":"A Strangfeld","year":"2021","unstructured":"Strangfeld, A. et al. Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 global rheumatology alliance physician-reported registry. Ann. Rheum. Dis. 80, 930\u2013942 (2021).","journal-title":"Ann. Rheum. Dis."},{"key":"618_CR39","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/s41581-021-00502-7","volume":"17","author":"M Prendecki","year":"2021","unstructured":"Prendecki, M., Willicombe, M. & McAdoo, S. P. COVID-19 vaccination in patients with immunity-mediated kidney disease. Nat. Rev. Nephrol. 17, 790\u2013791 (2021).","journal-title":"Nat. Rev. Nephrol."},{"key":"618_CR40","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1136\/annrheumdis-2021-221252","volume":"81","author":"CM Connolly","year":"2022","unstructured":"Connolly, C. M. et al. Temporary hold of mycophenolate augments humoral response to SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal diseases: a case series. Ann. Rheum. Dis. 81, 293\u2013295 (2022).","journal-title":"Ann. Rheum. Dis."},{"key":"618_CR41","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.kint.2021.11.013","volume":"101","author":"A Kronbichler","year":"2022","unstructured":"Kronbichler, A., Jung, S. Y., Kim, M. S. & Shin, J. I. Distinct glomerular disease association after vaccination with BNT162b2 and mRNA-1273: a VigiBase analysis. Kidney Int. 101, 415\u2013416 (2022).","journal-title":"Kidney Int."},{"key":"618_CR42","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.2215\/CJN.19141220","volume":"16","author":"MJ Oliver","year":"2021","unstructured":"Oliver, M. J. & Crabtree, J. H. Prioritizing peritoneal catheter placement during the COVID-19 pandemic: a perspective of the American Society of Nephrology COVID-19 Home Dialysis Subcommittee. Clin. J. Am. Soc. Nephrol. 16, 1281\u20131283 (2021).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"618_CR43","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.ekir.2021.12.011","volume":"7","author":"R Aylward","year":"2022","unstructured":"Aylward, R. et al. The global impact of the COVID-19 pandemic on in-center hemodialysis services: an ISN-dialysis outcomes practice patterns study survey. Kidney Int. Rep. 7, 397\u2013409 (2022).","journal-title":"Kidney Int. Rep."},{"key":"618_CR44","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1681\/ASN.2020040534","volume":"31","author":"RW Corbett","year":"2020","unstructured":"Corbett, R. W. et al. Epidemiology of COVID-19 in an urban dialysis center. J. Am. Soc. Nephrol. 31, 1815\u20131823 (2020).","journal-title":"J. Am. Soc. Nephrol."},{"key":"618_CR45","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1007\/s40620-021-01136-5","volume":"34","author":"G Alfano","year":"2021","unstructured":"Alfano, G. et al. The frail world of haemodialysis patients in the COVID-19 pandemic era: a systematic scoping review. J. Nephrol. 34, 1387\u20131403 (2021).","journal-title":"J. Nephrol."},{"key":"618_CR46","doi-asserted-by":"publisher","first-page":"825","DOI":"10.15585\/mmwr.mm7022e2","volume":"70","author":"R Ziemba","year":"2021","unstructured":"Ziemba, R. et al. Excess death estimates in patients with end-stage renal disease \u2014 United States, February\u2013August 2020. MMWR Morb. Mortal. Wkly. Rep. 70, 825\u2013829 (2021).","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"618_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2022.06.007","author":"P Vart","year":"2022","unstructured":"Vart, P. et al. COVID-19 pandemic waves and mortality among patients on kidney replacement therapy. Kidney Int. Rep. https:\/\/doi.org\/10.1016\/j.ekir.2022.06.007 (2022).","journal-title":"Kidney Int. Rep."},{"key":"618_CR48","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1001\/jamainternmed.2022.0627","volume":"182","author":"PR Patel","year":"2022","unstructured":"Patel, P. R. et al. Assessment of provision of COVID-19 vaccination in dialysis clinics and patient vaccination coverage. JAMA Intern. Med. 182, 676\u2013678 (2022).","journal-title":"JAMA Intern. Med."},{"key":"618_CR49","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1681\/ASN.2021050611","volume":"32","author":"Shuchi Anand","year":"2021","unstructured":"Anand, Shuchi et al. Antibody response to COVID-19 vaccination in patients receiving dialysis. J. Am. Soc. Nephrol. 32, 2435\u20132438 (2021).","journal-title":"J. Am. Soc. Nephrol."},{"key":"618_CR50","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2021101395","author":"SM Brunelli","year":"2022","unstructured":"Brunelli, S. M. et al. Comparative effectiveness of mRNA-based BNT162b2 vaccine versus adenovirus vector-based Ad26.COV2.S vaccine for the prevention of COVID-19 among dialysis patients. J. Am. Soc. Nephrol. https:\/\/doi.org\/10.1681\/ASN.2021101395 (2022).","journal-title":"J. Am. Soc. Nephrol."},{"key":"618_CR51","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1681\/ASN.2021070936","volume":"33","author":"P Garcia","year":"2022","unstructured":"Garcia, P. et al. COVID-19 vaccine type and humoral immune response in patients receiving dialysis. J. Am. Soc. Nephrol. 33, 33\u201337 (2022).","journal-title":"J. Am. Soc. Nephrol."},{"key":"618_CR52","first-page":"42132","volume":"85","author":"CMS.","year":"2020","unstructured":"CMS. Medicare Program; end-stage renal disease prospective payment system, payment for renal dialysis services furnished to individuals with acute kidney injury, and end-stage renal disease quality incentive program. Fed. Register 85, 42132\u201342208 CMS-1732-P. 42 CFR Part 413 (2020).","journal-title":"Fed. Register"},{"key":"618_CR53","first-page":"61114","volume":"85","author":"CMS, HHS.","year":"2020","unstructured":"CMS, HHS. Medicare Program; specialty care models to improve quality of care and reduce expenditures. Fed. Register 85, 61114\u201361381 CMS-5527-F (2020).","journal-title":"Fed. Register"},{"key":"618_CR54","unstructured":"CMS. COVID-19 Emergency Declaration Blanket Waivers for Health Care Providers. https:\/\/www.cms.gov\/files\/document\/summary-covid-19-emergency-declaration-waivers.pdf (2021)."},{"key":"618_CR55","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s40620-020-00737-w","volume":"33","author":"G Rombola","year":"2020","unstructured":"Rombola, G. & Brunini, F. COVID-19 and dialysis: why we should be worried. J. Nephrol. 33, 401\u2013403 (2020).","journal-title":"J. Nephrol."},{"key":"618_CR56","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1053\/j.ajkd.2019.01.023","volume":"74","author":"SQ Lew","year":"2019","unstructured":"Lew, S. Q. & Sikka, N. Operationalizing telehealth for home dialysis patients in the United States. Am. J. Kidney Dis. 74, 95\u2013100 (2019).","journal-title":"Am. J. Kidney Dis."},{"key":"618_CR57","doi-asserted-by":"publisher","first-page":"n2713","DOI":"10.1136\/bmj.n2713","volume":"375","author":"E Mahase","year":"2021","unstructured":"Mahase, E. COVID-19: Pfizer\u2019s paxlovid is 89% effective in patients at risk of serious illness, company reports. BMJ 375, n2713 (2021).","journal-title":"BMJ"},{"key":"618_CR58","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1080\/07853890.2022.2034936","volume":"54","author":"W Wen","year":"2022","unstructured":"Wen, W. et al. Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and paxlovid) for COVID-19: a meta-analysis. Ann. Med. 54, 516\u2013523 (2022).","journal-title":"Ann. Med."},{"key":"618_CR59","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1111\/ajt.16578","volume":"21","author":"JD Schold","year":"2021","unstructured":"Schold, J. D. et al. COVID-19 mortality among kidney transplant candidates is strongly associated with social determinants of health. Am. J. Transpl. 21, 2563\u20132572 (2021).","journal-title":"Am. J. Transpl."},{"key":"618_CR60","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.2215\/CJN.02690221","volume":"16","author":"S Mohan","year":"2021","unstructured":"Mohan, S., King, K. L., Husain, S. A. & Schold, J. D. COVID-19-associated mortality among kidney transplant recipients and candidates in the United States. Clin. J. Am. Soc. Nephrol. 16, 1695\u20131703 (2021).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"618_CR61","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-021-01214-8","author":"F Alberici","year":"2022","unstructured":"Alberici, F. et al. SARS-CoV-2 infection in dialysis and kidney transplant patients: immunological and serological response. J. Nephrol. https:\/\/doi.org\/10.1007\/s40620-021-01214-8 (2022).","journal-title":"J. Nephrol."},{"key":"618_CR62","doi-asserted-by":"publisher","first-page":"e709","DOI":"10.1016\/S2468-2667(21)00200-0","volume":"6","author":"O Aubert","year":"2021","unstructured":"Aubert, O. et al. COVID-19 pandemic and worldwide organ transplantation: a population-based study. Lancet Public Health 6, e709\u2013e719 (2021).","journal-title":"Lancet Public Health"},{"key":"618_CR63","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1016\/j.ekir.2020.08.017","volume":"5","author":"KL Lentine","year":"2020","unstructured":"Lentine, K. L. et al. Survey of US living kidney donation and transplantation practices in the COVID-19 era. Kidney Int. Rep. 5, 1894\u20131905 (2020).","journal-title":"Kidney Int. Rep."},{"key":"618_CR64","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1016\/j.ekir.2021.06.002","volume":"6","author":"MT Li","year":"2021","unstructured":"Li, M. T., King, K. L., Husain, S. A., Schold, J. D. & Mohan, S. Deceased donor kidneys utilization and discard rates during COVID-19 pandemic in the United States. Kidney Int. Rep. 6, 2463\u20132467 (2021).","journal-title":"Kidney Int. Rep."},{"key":"618_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.accpm.2022.101098","author":"R Martinez-Reviejo","year":"2022","unstructured":"Martinez-Reviejo, R. et al. Solid organ transplantation from donors with recent or current SARS-CoV-2 infection: a systematic review. Anaesth. Crit. Care Pain. Med. https:\/\/doi.org\/10.1016\/j.accpm.2022.101098 (2022).","journal-title":"Anaesth. Crit. Care Pain. Med."},{"key":"618_CR66","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1177\/15269248211046005","volume":"31","author":"JH Chang","year":"2021","unstructured":"Chang, J. H. et al. Home care delivery and remote patient monitoring of kidney transplant recipients during COVID-19 pandemic. Prog. Transpl. 31, 381\u2013384 (2021).","journal-title":"Prog. Transpl."},{"key":"618_CR67","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-021-01193-w","author":"L Biancone","year":"2022","unstructured":"Biancone, L. et al. Telemedicine monitoring in the follow-up of kidney transplant recipients: consensus indications from an Italian panel of surgeons and nephrologists after the COVID-19 experience. J. Nephrol. https:\/\/doi.org\/10.1007\/s40620-021-01193-w (2022).","journal-title":"J. Nephrol."},{"key":"618_CR68","doi-asserted-by":"publisher","first-page":"495","DOI":"10.23876\/j.krcp.20.107","volume":"39","author":"SR Potter","year":"2020","unstructured":"Potter, S. R., Hinojosa, R., Miles, C. D., O\u2019Brien, D. & Ross, D. J. Remote monitoring using donor-derived, cell-free DNA after kidney transplantation during the coronavirus disease 2019 pandemic. Kidney Res. Clin. Pract. 39, 495\u2013500 (2020).","journal-title":"Kidney Res. Clin. Pract."},{"key":"618_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2022.01.1072","author":"C Masset","year":"2022","unstructured":"Masset, C. et al. Occurrence of de novo donor specific antibodies after COVID-19 in kidney transplant recipients is low despite immunosuppression modulation. Kidney Int. Rep. https:\/\/doi.org\/10.1016\/j.ekir.2022.01.1072 (2022).","journal-title":"Kidney Int. Rep."},{"key":"618_CR70","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1053\/j.ackd.2020.07.004","volume":"27","author":"BG Abu Jawdeh","year":"2020","unstructured":"Abu Jawdeh, B. G. COVID-19 in kidney transplantation: outcomes, immunosuppression management, and operational challenges. Adv. Chronic Kidney Dis. 27, 383\u2013389 (2020).","journal-title":"Adv. Chronic Kidney Dis."},{"key":"618_CR71","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.ekir.2022.03.005","volume":"7","author":"Priti Meena","year":"2022","unstructured":"Meena, Priti & Crew, R. John Understanding the risks of immunosuppression reduction for active COVID-19 infection. Kidney Int. Rep. 7, 937\u2013938 (2022).","journal-title":"Kidney Int. Rep."},{"key":"618_CR72","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.14193","volume":"35","author":"DM Salerno","year":"2021","unstructured":"Salerno, D. M. et al. SARS-CoV-2 infection increases tacrolimus concentrations in solid-organ transplant recipients. Clin. Transpl. 35, e14193 (2021).","journal-title":"Clin. Transpl."},{"key":"618_CR73","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.16966","author":"SP Watcharananan","year":"2022","unstructured":"Watcharananan, S. P. et al. Comparison of the immunogenicity of ChAdOx1 nCoV-19 vaccine against the wild-type and delta variants in kidney transplant recipients and healthy volunteers. Am. J. Transpl. https:\/\/doi.org\/10.1111\/ajt.16966 (2022).","journal-title":"Am. J. Transpl."},{"key":"618_CR74","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1001\/jama.2021.7489","volume":"325","author":"BJ Boyarsky","year":"2021","unstructured":"Boyarsky, B. J. et al. Antibody response to 2-dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients. JAMA 325, 2204\u20132206 (2021).","journal-title":"JAMA"},{"key":"618_CR75","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.kint.2021.08.017","volume":"100","author":"C Masset","year":"2021","unstructured":"Masset, C. et al. A third injection of the BNT162b2 mRNA COVID-19 vaccine in kidney transplant recipients improves the humoral immune response. Kidney Int. 100, 1132\u20131135 (2021).","journal-title":"Kidney Int."},{"key":"618_CR76","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.kint.2021.11.024","volume":"101","author":"C Masset","year":"2022","unstructured":"Masset, C. et al. Observations on improving COVID-19 vaccination responses in kidney transplant recipients: heterologous vaccination and immunosuppression modulation. Kidney Int. 101, 642\u2013645 (2022).","journal-title":"Kidney Int."},{"key":"618_CR77","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000004219","author":"MP Cristelli","year":"2022","unstructured":"Cristelli, M. P., Nakamura, M. R., Viana, L. A., Tedesco-Silva, H. & Medina-Pestana, J. The fourth dose of coronavac vaccine results in a small increase of seroconversion and antibody values among kidney transplant recipients. Transplantation https:\/\/doi.org\/10.1097\/TP.0000000000004219 (2022).","journal-title":"Transplantation"},{"key":"618_CR78","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s00467-020-04764-4","volume":"36","author":"O Charnaya","year":"2021","unstructured":"Charnaya, O. et al. Effects of COVID-19 pandemic on pediatric kidney transplant in the United States. Pediatr. Nephrol. 36, 143\u2013151 (2021).","journal-title":"Pediatr. Nephrol."},{"key":"618_CR79","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2020-320616","author":"M Marlais","year":"2020","unstructured":"Marlais, M. et al. COVID-19 in children treated with immunosuppressive medication for kidney diseases. Arch. Dis. Child. https:\/\/doi.org\/10.1136\/archdischild-2020-320616 (2020).","journal-title":"Arch. Dis. Child."},{"key":"618_CR80","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1111\/ajt.16501","volume":"21","author":"CD Varnell","year":"2021","unstructured":"Varnell, C. D. et al. COVID-19 in pediatric kidney transplantation: the improving renal outcomes collaborative. Am. J. Transpl. 21, 2740\u20132748 (2021).","journal-title":"Am. J. Transpl."},{"key":"618_CR81","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s00431-021-04191-z","volume":"181","author":"N Canpolat","year":"2022","unstructured":"Canpolat, N. et al. COVID-19 in pediatric patients undergoing chronic dialysis and kidney transplantation. Eur. J. Pediatr. 181, 117\u2013123 (2022).","journal-title":"Eur. J. Pediatr."},{"key":"618_CR82","doi-asserted-by":"publisher","first-page":"449","DOI":"10.2215\/CJN.13120820","volume":"16","author":"A Mastrangelo","year":"2021","unstructured":"Mastrangelo, A. et al. Impact of COVID-19 pandemic in children with CKD or immunosuppression. Clin. J. Am. Soc. Nephrol. 16, 449\u2013451 (2021).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"618_CR83","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.kint.2021.02.026","volume":"100","author":"A Basalely","year":"2021","unstructured":"Basalely, A. et al. Acute kidney injury in pediatric patients hospitalized with acute COVID-19 and multisystem inflammatory syndrome in children associated with COVID-19. Kidney Int. 100, 138\u2013145 (2021).","journal-title":"Kidney Int."},{"key":"618_CR84","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12882-021-02389-9","volume":"22","author":"JA Kari","year":"2021","unstructured":"Kari, J. A. et al. Acute kidney injury in children with COVID-19: a retrospective study. BMC Nephrol. 22, 202 (2021).","journal-title":"BMC Nephrol."},{"key":"618_CR85","doi-asserted-by":"publisher","DOI":"10.1093\/tropej\/fmab037","author":"S Chopra","year":"2021","unstructured":"Chopra, S. et al. Acute kidney injury in hospitalized children with COVID19. J. Trop. Pediatr. https:\/\/doi.org\/10.1093\/tropej\/fmab037 (2021).","journal-title":"J. Trop. Pediatr."},{"key":"618_CR86","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s00467-020-04715-z","volume":"36","author":"X Wang","year":"2021","unstructured":"Wang, X. et al. Be aware of acute kidney injury in critically ill children with COVID-19. Pediatr. Nephrol. 36, 163\u2013169 (2021).","journal-title":"Pediatr. Nephrol."},{"key":"618_CR87","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1611391","volume":"376","author":"A Kaddourah","year":"2017","unstructured":"Kaddourah, A., Basu, R. K., Bagshaw, S. M. & Goldstein, S. L., AWARE Investigators. Epidemiology of acute kidney injury in critically ill children and young adults. N. Engl. J. Med. 376, 11\u201320 (2017).","journal-title":"N. Engl. J. Med."},{"key":"618_CR88","doi-asserted-by":"publisher","unstructured":"No authors listed. Long COVID and kids: more research is urgently needed. Nature https:\/\/doi.org\/10.1038\/d41586-022-00334-w (2022).","DOI":"10.1038\/d41586-022-00334-w"},{"key":"618_CR89","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.14364","volume":"75","author":"M Yilmaz","year":"2021","unstructured":"Yilmaz, M. & Sahin, M. K. Parents\u2019 willingness and attitudes concerning the COVID-19 vaccine: a cross-sectional study. Int. J. Clin. Pract. 75, e14364 (2021).","journal-title":"Int. J. Clin. Pract."},{"key":"618_CR90","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.1007\/s00467-021-05041-8","volume":"36","author":"Y Tse","year":"2021","unstructured":"Tse, Y. et al. COVID-19: experiences of lockdown and support needs in children and young adults with kidney conditions. Pediatr. Nephrol. 36, 2797\u20132810 (2021).","journal-title":"Pediatr. Nephrol."},{"key":"618_CR91","unstructured":"Acemoglu, D., Chernozhukov, V., Werning, I. & Whinston, M. D. A Multi-Risk SIR Model with Optimally Targeted Lockdown. Vol. 2020 (National Bureau of Economic Research Cambridge, 2020)."},{"key":"618_CR92","first-page":"357","volume":"5","author":"Z Neufeld","year":"2020","unstructured":"Neufeld, Z., Khataee, H. & Czirok, A. Targeted adaptive isolation strategy for COVID-19 pandemic. Infect. Dis. Model. 5, 357\u2013361 (2020).","journal-title":"Infect. Dis. Model."},{"key":"618_CR93","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1093\/rheumatology\/keaa620","volume":"60","author":"M Rutter","year":"2020","unstructured":"Rutter, M. et al. Estimation of the burden of shielding among a cross-section of patients attending rheumatology clinics with SLE \u2014 data from the BSR audit of systemic lupus erythematosus. Rheumatology 60, 1474\u20131479 (2020).","journal-title":"Rheumatology"},{"key":"618_CR94","doi-asserted-by":"publisher","DOI":"10.1093\/rap\/rkab003","author":"M Sloan","year":"2021","unstructured":"Sloan, M. et al. COVID-19 and shielding: experiences of UK patients with lupus and related diseases. Rheumatol. Adv. Pract. https:\/\/doi.org\/10.1093\/rap\/rkab003 (2021).","journal-title":"Rheumatol. Adv. Pract."},{"key":"618_CR95","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-040910","volume":"10","author":"M Qian","year":"2020","unstructured":"Qian, M. et al. Anxiety levels, precautionary behaviours and public perceptions during the early phase of the COVID-19 outbreak in China: a population-based cross-sectional survey. BMJ Open 10, e040910 (2020).","journal-title":"BMJ Open"},{"key":"618_CR96","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1080\/13548506.2020.1776891","volume":"26","author":"M Y\u0131ld\u0131r\u0131m","year":"2021","unstructured":"Y\u0131ld\u0131r\u0131m, M., Ge\u00e7er, E. & Akg\u00fcl, \u00d6. The impacts of vulnerability, perceived risk, and fear on preventive behaviours against COVID-19. Psychol. Health Med. 26, 35\u201343 (2021).","journal-title":"Psychol. Health Med."},{"key":"618_CR97","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/s41562-020-0884-z","volume":"4","author":"JJV Bavel","year":"2020","unstructured":"Bavel, J. J. V. et al. Using social and behavioural science to support COVID-19 pandemic response. Nat. Hum. Behav. 4, 460\u2013471 (2020).","journal-title":"Nat. Hum. Behav."},{"key":"618_CR98","doi-asserted-by":"crossref","unstructured":"Lanphier, E., Mosley, L. & Antommaria, A. H. M. Assessing visitor policy exemption requests during the COVID-19 pandemic. Pediatrics 148, e2021051254 (2021).","DOI":"10.1542\/peds.2021-051254"},{"key":"618_CR99","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S2213-2600(21)00025-4","volume":"9","author":"J Downar","year":"2021","unstructured":"Downar, J. & Kekewich, M. Improving family access to dying patients during the COVID-19 pandemic. Lancet Respir. Med. 9, 335\u2013337 (2021).","journal-title":"Lancet Respir. Med."},{"key":"618_CR100","doi-asserted-by":"publisher","first-page":"264","DOI":"10.5501\/wjv.v10.i5.264","volume":"10","author":"GM Nogueira","year":"2021","unstructured":"Nogueira, G. M., Oliveira, M. S., Moura, A. F., Cruz, C. M. S. & Moura-Neto, J. A. COVID-19 in dialysis units: a comprehensive review. World J. Virol. 10, 264 (2021).","journal-title":"World J. Virol."},{"key":"618_CR101","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/SPC.0000000000000567","volume":"15","author":"DJ Janssen","year":"2021","unstructured":"Janssen, D. J. Palliative care in COVID-19. Curr. Opin. Support. Palliat. Care 15, 199 (2021).","journal-title":"Curr. Opin. Support. Palliat. Care"},{"key":"618_CR102","doi-asserted-by":"publisher","first-page":"104000","DOI":"10.1016\/j.ijnurstu.2021.104000","volume":"121","author":"K Hugelius","year":"2021","unstructured":"Hugelius, K., Harada, N. & Marutani, M. Consequences of visiting restrictions during the COVID\u201019 pandemic: an integrative review. Int. J. Nurs. Stud. 121, 104000 (2021).","journal-title":"Int. J. Nurs. Stud."},{"key":"618_CR103","doi-asserted-by":"crossref","unstructured":"Vittone, S. & Sotomayor, C. R. in HEC forum. Vol. 33, 415\u2013423 (Springer, 2021).","DOI":"10.1007\/s10730-021-09450-y"},{"key":"618_CR104","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.semnephrol.2021.05.006","volume":"41","author":"K Ducharlet","year":"2021","unstructured":"Ducharlet, K. et al. Moral distress and moral injury in nephrology during the COVID-19 pandemic. Semin. Nephrol. 41, 253\u2013261 (2021).","journal-title":"Semin. Nephrol."},{"key":"618_CR105","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab937","author":"M Sloan","year":"2022","unstructured":"Sloan, M. et al. Will \u2018the feeling of abandonment\u2019 remain? Persisting impacts of the COVID-19 pandemic on rheumatology patients and clinicians. Rheumatology https:\/\/doi.org\/10.1093\/rheumatology\/keab937 (2022).","journal-title":"Rheumatology"},{"key":"618_CR106","doi-asserted-by":"publisher","first-page":"102780","DOI":"10.1016\/j.nepr.2020.102780","volume":"44","author":"SC Shaw","year":"2020","unstructured":"Shaw, S. C. Hopelessness, helplessness and resilience: the importance of safeguarding our trainees\u2019 mental wellbeing during the COVID-19 pandemic. Nurse Educ. Pract. 44, 102780 (2020).","journal-title":"Nurse Educ. Pract."},{"key":"618_CR107","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1097\/ACM.0000000000003414","volume":"95","author":"J Ripp","year":"2020","unstructured":"Ripp, J., Peccoralo, L. & Charney, D. Attending to the emotional well-being of the health care workforce in a New York City health system during the COVID-19 pandemic. Acad. Med. 95, 1136\u20131139 (2020).","journal-title":"Acad. Med."},{"key":"618_CR108","doi-asserted-by":"publisher","unstructured":"Morley, G., Sese, D., Rajendram, P. & Horsburgh, C. C. Addressing caregiver moral distress during the COVID-19 pandemic. Cleve. Clin. J. Med. https:\/\/doi.org\/10.3949\/ccjm.87a.ccc047 (2020).","DOI":"10.3949\/ccjm.87a.ccc047"},{"key":"618_CR109","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12882-021-02500-0","volume":"22","author":"C Mc Keaveney","year":"2021","unstructured":"McKeaveney, C. et al. Experiences of renal healthcare practitioners during the COVID-19 pandemic: a multi-methods approach. BMC Nephrol. 22, 1\u201310 (2021).","journal-title":"BMC Nephrol."},{"key":"618_CR110","unstructured":"Jameton, A. Nursing Practice: The Ethical Issues (Prentice-Hall, 1984)."},{"key":"618_CR111","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12882-020-01732-w","volume":"21","author":"D Flood","year":"2020","unstructured":"Flood, D. et al. Challenges in the provision of kidney care at the largest public nephrology center in Guatemala: a qualitative study with health professionals. BMC Nephrol. 21, 1\u201310 (2020).","journal-title":"BMC Nephrol."},{"key":"618_CR112","doi-asserted-by":"publisher","DOI":"10.7326\/M18-0400","author":"L Cervantes","year":"2018","unstructured":"Cervantes, L. et al. Clinicians\u2019 perspectives on providing emergency-only hemodialysis to undocumented immigrants: a qualitative study. Ann. Intern. Med. https:\/\/doi.org\/10.7326\/M18-0400 (2018).","journal-title":"Ann. Intern. Med."},{"key":"618_CR113","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1177\/1359105315595120","volume":"22","author":"G Lamiani","year":"2017","unstructured":"Lamiani, G., Borghi, L. & Argentero, P. When healthcare professionals cannot do the right thing: a systematic review of moral distress and its correlates. J. Health Psychol. 22, 51\u201367 (2017).","journal-title":"J. Health Psychol."},{"key":"618_CR114","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.43160","volume":"5","author":"DT Myran","year":"2022","unstructured":"Myran, D. T. et al. Physician health care visits for mental health and substance use during the COVID-19 pandemic in Ontario, Canada. JAMA Netw. Open 5, e2143160 (2022).","journal-title":"JAMA Netw. Open"},{"key":"618_CR115","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.cpr.2009.07.003","volume":"29","author":"BT Litz","year":"2009","unstructured":"Litz, B. T. et al. Moral injury and moral repair in war veterans: a preliminary model and intervention strategy. Clin. Psychol. Rev. 29, 695\u2013706 (2009).","journal-title":"Clin. Psychol. Rev."},{"key":"618_CR116","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18094563","author":"H Nobari","year":"2021","unstructured":"Nobari, H. et al. Effect of COVID-19 on health-related quality of life in adolescents and children: a systematic review. Int. J. Environ. Res. Public Health https:\/\/doi.org\/10.3390\/ijerph18094563 (2021).","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"618_CR117","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcped.2022.01.003","author":"R Sharma","year":"2022","unstructured":"Sharma, R. et al. Distress, anxiety, and its correlates among caregivers of children with kidney diseases during COVID-19 pandemic lockdown. Arch. Pediatr. https:\/\/doi.org\/10.1016\/j.arcped.2022.01.003 (2022).","journal-title":"Arch. Pediatr."},{"key":"618_CR118","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-85874-3","volume":"11","author":"J Alessi","year":"2021","unstructured":"Alessi, J., de Oliveira, G. B., Feiden, G., Schaan, B. D. & Telo, G. H. Caring for caregivers: the impact of the COVID-19 pandemic on those responsible for children and adolescents with type 1 diabetes. Sci. Rep. 11, 6812 (2021).","journal-title":"Sci. Rep."},{"key":"618_CR119","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.pcl.2021.05.013","volume":"68","author":"LC Smitherman","year":"2021","unstructured":"Smitherman, L. C., Golden, W. C. & Walton, J. R. Health disparities and their effects on children and their caregivers during the coronavirus disease 2019 pandemic. Pediatr. Clin. North. Am. 68, 1133\u20131145 (2021).","journal-title":"Pediatr. Clin. North. Am."},{"key":"618_CR120","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/S0140-6736(21)02344-8","volume":"399","author":"S Moon","year":"2022","unstructured":"Moon, S. et al. Governing the access to COVID-19 tools accelerator: towards greater participation, transparency, and accountability. Lancet 399, 487\u2013494 (2022).","journal-title":"Lancet"},{"key":"618_CR121","doi-asserted-by":"publisher","first-page":"m4853","DOI":"10.1136\/bmj.m4853","volume":"372","author":"LM Herzog","year":"2021","unstructured":"Herzog, L. M., Norheim, O. F., Emanuel, E. J. & McCoy, M. S. Covax must go beyond proportional allocation of covid vaccines to ensure fair and equitable access. BMJ 372, m4853 (2021).","journal-title":"BMJ"},{"key":"618_CR122","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/S0140-6736(21)02835-X","volume":"399","author":"PB McIntyre","year":"2022","unstructured":"McIntyre, P. B. et al. COVID-19 vaccine strategies must focus on severe disease and global equity. Lancet 399, 406\u2013410 (2022).","journal-title":"Lancet"},{"key":"618_CR123","doi-asserted-by":"publisher","first-page":"e1169","DOI":"10.1016\/S2214-109X(21)00180-7","volume":"9","author":"A Binagwaho","year":"2021","unstructured":"Binagwaho, A., Mathewos, K. & Davis, S. Time for the ethical management of COVID-19 vaccines. Lancet Glob. Health 9, e1169\u2013e1171 (2021).","journal-title":"Lancet Glob. Health"},{"key":"618_CR124","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/S0140-6736(21)00151-3","volume":"397","author":"MS Patel","year":"2021","unstructured":"Patel, M. S. & Phillips, C. B. COVID-19 and the moral imagination. Lancet 397, 648\u2013650 (2021).","journal-title":"Lancet"},{"key":"618_CR125","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2020-004087","author":"SJ Ismail","year":"2021","unstructured":"Ismail, S. J., Tunis, M. C., Zhao, L. & Quach, C. Navigating inequities: a roadmap out of the pandemic. BMJ Glob. Health https:\/\/doi.org\/10.1136\/bmjgh-2020-004087 (2021).","journal-title":"BMJ Glob. Health"},{"key":"618_CR126","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s41581-020-00389-w","volume":"17","author":"ONR Bignall 2nd","year":"2021","unstructured":"Bignall, O. N. R. 2nd & Crews, D. C. Stony the road we trod: towards racial justice in kidney care. Nat. Rev. Nephrol. 17, 79\u201380 (2021).","journal-title":"Nat. Rev. Nephrol."},{"key":"618_CR127","doi-asserted-by":"publisher","DOI":"10.1186\/s12939-020-01218-z","volume":"19","author":"E Shadmi","year":"2020","unstructured":"Shadmi, E. et al. Health equity and COVID-19: global perspectives. Int. J. Equity Health 19, 104 (2020).","journal-title":"Int. J. Equity Health"},{"key":"618_CR128","doi-asserted-by":"publisher","first-page":"88","DOI":"10.12688\/wellcomeopenres.15922.2","volume":"5","author":"RW Aldridge","year":"2020","unstructured":"Aldridge, R. W. et al. Black, Asian and minority ethnic groups in England are at increased risk of death from COVID-19: indirect standardisation of NHS mortality data. Wellcome Open Res. 5, 88 (2020).","journal-title":"Wellcome Open Res."},{"key":"618_CR129","doi-asserted-by":"publisher","first-page":"e1018","DOI":"10.1016\/S2214-109X(20)30285-0","volume":"8","author":"P Baqui","year":"2020","unstructured":"Baqui, P., Bica, I., Marra, V., Ercole, A. & van der Schaar, M. Ethnic and regional variations in hospital mortality from COVID-19 in Brazil: a cross-sectional observational study. Lancet Glob. Health 8, e1018\u2013e1026 (2020).","journal-title":"Lancet Glob. Health"},{"key":"618_CR130","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1177\/1090198120922942","volume":"47","author":"WN Laster Pirtle","year":"2020","unstructured":"Laster Pirtle, W. N. Racial capitalism: a fundamental cause of novel coronavirus (COVID-19) pandemic inequities in the United States. Health Educ. Behav. 47, 504\u2013508 (2020).","journal-title":"Health Educ. Behav."},{"key":"618_CR131","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2020-002913","author":"S Yaya","year":"2020","unstructured":"Yaya, S., Yeboah, H., Charles, C. H., Otu, A. & Labonte, R. Ethnic and racial disparities in COVID-19-related deaths: counting the trees, hiding the forest. BMJ Glob. Health https:\/\/doi.org\/10.1136\/bmjgh-2020-002913 (2020).","journal-title":"BMJ Glob. Health"},{"key":"618_CR132","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/ndt\/gfaa314","volume":"36","author":"E-E Council","year":"2021","unstructured":"Council, E.- E. & Group, E. W. Chronic kidney disease is a key risk factor for severe COVID-19: a call to action by the ERA-EDTA. Nephrol. Dial. Transpl. 36, 87\u201394 (2021).","journal-title":"Nephrol. Dial. Transpl."},{"key":"618_CR133","unstructured":"WHO NCD Department. COVID-19 AND NCDS, https:\/\/www.google.com\/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwiMjPyu7ovrAhVt-yoKHU2MBi0QFjAIegQICBAB&url=https%3A%2F%2Fwww.who.int%2Fdocs%2Fdefault-source%2Fncds%2Fncd-covid-19%2Ffor-web---rapid-assessment---29-may-2020-(cleared).pdf%3Fsfvrsn%3D6296324c_8%26download%3Dtrue&usg=AOvVaw2fh7BVQyYEc4eozvMEaZxT (2020)."},{"key":"618_CR134","doi-asserted-by":"publisher","first-page":"747","DOI":"10.34067\/KID.0006932020","volume":"2","author":"VA Luyckx","year":"2021","unstructured":"Luyckx, V. A. Equity is key to build back better after COVID-19: prioritize noncommunicable diseases and kidney health. Kidney360 2, 747\u2013750 (2021).","journal-title":"Kidney360"},{"key":"618_CR135","doi-asserted-by":"publisher","first-page":"469","DOI":"10.23736\/S0375-9393.20.14619-4","volume":"86","author":"M Vergano","year":"2020","unstructured":"Vergano, M. et al. SIAARTI recommendations for the allocation of intensive care treatments in exceptional, resource-limited circumstances. Minerva Anestesiol. 86, 469\u2013472 (2020).","journal-title":"Minerva Anestesiol."},{"key":"618_CR136","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1111\/bioe.12805","volume":"34","author":"S Jobges","year":"2020","unstructured":"Jobges, S., Vinay, R., Luyckx, V. A. & Biller-Andorno, N. Recommendations on COVID-19 triage: international comparison and ethical analysis. Bioethics 34, 948\u2013959 (2020).","journal-title":"Bioethics"},{"key":"618_CR137","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41581-021-00404-8","volume":"17","author":"MR Moosa","year":"2021","unstructured":"Moosa, M. R. & Luyckx, V. A. The realities of rationing in health care. Nat. Rev. Nephrol. 17, 435\u2013436 (2021).","journal-title":"Nat. Rev. Nephrol."},{"key":"618_CR138","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-020-00702-7","volume":"10","author":"R Robert","year":"2020","unstructured":"Robert, R. et al. Ethical dilemmas due to the COVID-19 pandemic. Ann. Intensive Care 10, 84 (2020).","journal-title":"Ann. Intensive Care"},{"key":"618_CR139","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.5046","author":"DB White","year":"2020","unstructured":"White, D. B. & Lo, B. A framework for rationing ventilators and critical care beds during the COVID-19 pandemic. JAMA https:\/\/doi.org\/10.1001\/jama.2020.5046 (2020).","journal-title":"JAMA"},{"key":"618_CR140","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.27315","volume":"3","author":"CR Butler","year":"2020","unstructured":"Butler, C. R., Wong, S. P. Y., Wightman, A. G. & O\u2019Hare, A. M. US clinicians\u2019 experiences and perspectives on resource limitation and patient care during the COVID-19 pandemic. JAMA Netw. Open 3, e2027315 (2020).","journal-title":"JAMA Netw. Open"},{"key":"618_CR141","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.ekir.2020.06.033","volume":"5","author":"JS Stevens","year":"2020","unstructured":"Stevens, J. S. et al. Dashboards to facilitate nephrology disaster planning in the COVID-19 era. Kidney Int. Rep. 5, 1298\u20131302 (2020).","journal-title":"Kidney Int. Rep."},{"key":"618_CR142","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1681\/ASN.2016010027","volume":"27","author":"JM Norton","year":"2016","unstructured":"Norton, J. M. et al. Social determinants of racial disparities in CKD. J. Am. Soc. Nephrol. 27, 2576\u20132595 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"618_CR143","doi-asserted-by":"publisher","first-page":"276","DOI":"10.14740\/jocmr4160","volume":"12","author":"S Adapa","year":"2020","unstructured":"Adapa, S. et al. COVID-19 and renal failure: challenges in the delivery of renal replacement therapy. J. Clin. Med. Res. 12, 276 (2020).","journal-title":"J. Clin. Med. Res."},{"key":"618_CR144","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1001\/jama.2020.4169","volume":"323","author":"J Hopman","year":"2020","unstructured":"Hopman, J., Allegranzi, B. & Mehtar, S. Managing COVID-19 in low-and middle-income countries. JAMA 323, 1549\u20131550 (2020).","journal-title":"JAMA"},{"key":"618_CR145","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2022.02.027","author":"EK Tannor","year":"2022","unstructured":"Tannor, E. K. et al. The COVID-19 pandemic identifies significant global inequities in hemodialysis care in low and lower middle-income countries \u2014 an ISN\/DOPPS survey. Kidney Int. Rep. https:\/\/doi.org\/10.1016\/j.ekir.2022.02.027 (2022).","journal-title":"Kidney Int. Rep."},{"key":"618_CR146","doi-asserted-by":"publisher","DOI":"10.1080\/17441692.2021.1987502","author":"KT Storeng","year":"2021","unstructured":"Storeng, K. T., de Bengy Puyvallee, A. & Stein, F. COVAX and the rise of the \u2018super public private partnership\u2019 for global health. Glob. Public Health https:\/\/doi.org\/10.1080\/17441692.2021.1987502 (2021).","journal-title":"Glob. Public Health"},{"key":"618_CR147","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2021-007763","author":"KT Storeng","year":"2021","unstructured":"Storeng, K. T., Stein, F. & de Bengy Puyvallee, A. COVAX and the many meanings of sharing. BMJ Glob. Health https:\/\/doi.org\/10.1136\/bmjgh-2021-007763 (2021).","journal-title":"BMJ Glob. Health"},{"key":"618_CR148","doi-asserted-by":"publisher","DOI":"10.34172\/ijhpm.2021.49","author":"A Binagwaho","year":"2021","unstructured":"Binagwaho, A., Mathewos, K. & Davis, S. Equitable and effective distribution of the COVID-19 vaccines \u2014 a scientific and moral obligation. Int. J. Health Policy Manag. https:\/\/doi.org\/10.34172\/ijhpm.2021.49 (2021).","journal-title":"Int. J. Health Policy Manag."},{"key":"618_CR149","doi-asserted-by":"publisher","first-page":"194","DOI":"10.2215\/CJN.11020720","volume":"16","author":"LA Plumb","year":"2021","unstructured":"Plumb, L. A. et al. Associations between deprivation, geographic location, and access to pediatric kidney care in the United Kingdom. Clin. J. Am. Soc. Nephrol. 16, 194\u2013203 (2021).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"618_CR150","doi-asserted-by":"publisher","first-page":"185","DOI":"10.2215\/CJN.19321220","volume":"16","author":"AM Goldberg","year":"2021","unstructured":"Goldberg, A. M. & Bignall, O. N. R. 2nd Mind the gap: acknowledging deprivation is key to narrowing kidney health disparities in both children and adults. Clin. J. Am. Soc. Nephrol. 16, 185\u2013187 (2021).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"618_CR151","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfab276","author":"G Alfano","year":"2021","unstructured":"Alfano, G. et al. Ethical challenges in managing unvaccinated patients receiving chronic in-centre haemodialysis. Clin. Kidney J. https:\/\/doi.org\/10.1093\/ckj\/sfab276 (2021).","journal-title":"Clin. Kidney J."},{"key":"618_CR152","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/S0140-6736(20)31417-3","volume":"396","author":"AL Taylor","year":"2020","unstructured":"Taylor, A. L. et al. Solidarity in the wake of COVID-19: reimagining the International Health Regulations. Lancet 396, 82\u201383 (2020).","journal-title":"Lancet"},{"key":"618_CR153","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1681\/ASN.2020111636","volume":"32","author":"KA Pivert","year":"2021","unstructured":"Pivert, K. A. et al. Impact of the COVID-19 pandemic on nephrology fellow training and well-being in the United States: a National Survey. J. Am. Soc. Nephrol. 32, 1236\u20131248 (2021).","journal-title":"J. Am. Soc. Nephrol."},{"key":"618_CR154","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1093\/ckj\/sfab264","volume":"15","author":"H Selvaskandan","year":"2022","unstructured":"Selvaskandan, H. et al. Burnout and long COVID among the UK nephrology workforce: results from a national survey investigating the impact of COVID-19 on working lives. Clin. Kidney J. 15, 517\u2013526 (2022).","journal-title":"Clin. Kidney J."},{"key":"618_CR155","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.ekir.2021.12.035","volume":"7","author":"V Maisons","year":"2022","unstructured":"Maisons, V. et al. Impact of the COVID-19 pandemic on training and well-being of nephrology residents in France and Belgium. Kidney Int. Rep. 7, 653\u2013655 (2022).","journal-title":"Kidney Int. Rep."},{"key":"618_CR156","doi-asserted-by":"publisher","DOI":"10.1177\/2054358120988446","volume":"8","author":"A Cunningham","year":"2021","unstructured":"Cunningham, A., Hung, W., Levin, A. & Jamal, A. Adapting nephrology training curriculum in the era of COVID-19. Can. J. Kidney Health Dis. 8, 2054358120988446 (2021).","journal-title":"Can. J. Kidney Health Dis."},{"key":"618_CR157","doi-asserted-by":"publisher","DOI":"10.1111\/jorc.12419","author":"C Ewart","year":"2022","unstructured":"Ewart, C., Baharani, J., Wilkie, M. & Thomas, N. Patient perspectives and experiences of remote consultations in people receiving kidney care: a scoping review. J. Ren. Care https:\/\/doi.org\/10.1111\/jorc.12419 (2022).","journal-title":"J. Ren. Care"}],"updated-by":[{"DOI":"10.1038\/s41581-022-00635-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T00:00:00Z","timestamp":1663632000000}}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41581-022-00618-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-022-00618-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-022-00618-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T09:06:55Z","timestamp":1666084015000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41581-022-00618-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,24]]},"references-count":157,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["618"],"URL":"https:\/\/doi.org\/10.1038\/s41581-022-00618-4","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,24]]},"assertion":[{"value":"29 July 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2022","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41581-022-00635-3","URL":"https:\/\/doi.org\/10.1038\/s41581-022-00635-3","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.G. is a consultant to ChemoCentryx, Aurinia Inc and GSK, and received support from the Johns Hopkins Center for Innovative Medicine. A.K. is a consultant to Vifor, Otsuka, Delta4, Catalyst Biosciences and UriSalt, and received funding from Vifor and Otsuka. M.R. is funded by a Versus Arthritis Clinical Research Fellowship. S.A. has a grant from the National Institute of Diabetes and Digestive and Kidney Diseases (R01DK127138); Ascend Clinical Laboratory funded sample testing for S.A.\u2019s work on SARS-CoV-2 seroepidemiology among patients on dialysis. E.L. received a consulting fee from Acumen, LLC, a federal contractor, and funding from National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (K08 DK118213) and from the University Kidney Research Organization. V.T. is a consultant for AbbVie, Amgen, Baxter, Bayer, Boehringer Ingelheim, Calliditas, ChemoCentryx and Fresenius Medical Care, Omeros and Travere. V.T. is also a speaker for Bayer and Boehringer Ingelheim, and received travel expenses from AbbVie. D.C. was supported by grant 1 K24 HL148181 from the National Heart, Lung and Blood Institute, National Institutes of Health (NIH), and received research grant funding from Somatus Medical, Inc. and Baxter International, for unrelated work. N.C. received lecture fees Bristol Myers Squibb, and funding from The Danish Heart Foundation. V.J. received grant funding from GSK, Baxter Healthcare and Biocon, and honoraria from Bayer, AstraZeneca, Boehringer Ingelheim, NephroPlus and Zydus Cadilla, under the policy of all monies being paid to the organization. S.M. received grants from the NIH (DK126739, DK114893, DK130058, MD014161, DK116066) and the Kidney Transplant collaborative as well as personal fees from Kidney International Reports and HSAG, outside the submitted work. C.P. is a member of the advisory board of and owns equity in RenalytixAI, serves as a consultant for Genfit and Novartis, and is supported by NIH grants R01HL085757, UH3DK114866, U01DK106962 and R01DK093770. V.L. received funding from the Swiss Kidney Foundation. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}